IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.141
NA - Nord America 1.210
EU - Europa 646
OC - Oceania 24
AF - Africa 18
SA - Sud America 11
Totale 4.050
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.435
US - Stati Uniti d'America 1.164
HK - Hong Kong 305
CN - Cina 293
GB - Regno Unito 208
IT - Italia 186
DE - Germania 79
CA - Canada 41
IN - India 41
NL - Olanda 41
AU - Australia 23
CZ - Repubblica Ceca 22
TR - Turchia 22
FI - Finlandia 21
FR - Francia 20
UA - Ucraina 16
RU - Federazione Russa 13
CH - Svizzera 9
ZA - Sudafrica 9
JP - Giappone 7
PL - Polonia 7
SA - Arabia Saudita 7
ID - Indonesia 6
BR - Brasile 5
PH - Filippine 5
BE - Belgio 4
CL - Cile 4
ES - Italia 4
AT - Austria 3
BA - Bosnia-Erzegovina 3
IR - Iran 3
MA - Marocco 3
AE - Emirati Arabi Uniti 2
CM - Camerun 2
EE - Estonia 2
HU - Ungheria 2
IE - Irlanda 2
KR - Corea 2
KZ - Kazakistan 2
MW - Malawi 2
MX - Messico 2
VN - Vietnam 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MS - Montserrat 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 4.050
Salva come PNG Salva come JPEG
Città #
Singapore 491
Ashburn 313
Hong Kong 288
Boardman 264
London 190
Shanghai 188
Rome 78
Council Bluffs 51
San Francisco 45
West Jordan 41
Los Angeles 40
Seattle 37
Toronto 37
Pune 32
Washington 26
Amsterdam 22
Brno 22
Helsinki 21
Sona 20
Munich 16
Santa Clara 15
Central 11
Canberra 9
Melbourne 9
Milan 9
Paris 8
Guangzhou 7
Warsaw 7
Frankfurt am Main 6
Haikou 6
Redmond 6
Riyadh 6
Moscow 5
New York 5
Zhengzhou 5
Berlin 4
Hanover 4
Naples 4
Tokyo 4
Bologna 3
Brownsville 3
Charlotte 3
Delhi 3
Hefei 3
Jinan 3
Newark 3
Pamplona 3
Rabat 3
Sarajevo 3
Sydney 3
São Paulo 3
Taranto 3
Vienna 3
Almere Stad 2
Anderlecht 2
Andover 2
Boydton 2
Buffalo 2
Cervignano del Friuli 2
Chengdu 2
Cinisello Balsamo 2
Cuijk 2
Douala 2
Dublin 2
Falls Church 2
Fara in Sabina 2
Ferrara di Monte Baldo 2
Foligno 2
Handan 2
Hangzhou 2
Ho Chi Minh City 2
Houston 2
Kharkiv 2
Kyiv 2
Liverpool 2
Manila 2
Markham 2
Messina 2
Mexico City 2
Perugia 2
Rockville 2
Rovereto 2
Shenzhen 2
Tianjin 2
Ajman 1
Amman 1
Baltimore 1
Baoding 1
Basingstoke 1
Beijing 1
Borås 1
Brescia 1
Budapest 1
Casalecchio di Reno 1
Changchun 1
Changsha 1
Changzhou 1
Chicago 1
Chongqing 1
Cleveland 1
Totale 2.472
Salva come PNG Salva come JPEG
Nome #
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 38
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 37
Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates 33
Enhanced portal flow velocity and volume following Iloprost treatment 33
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 32
GH-resistance in different stages of chronic liver disease 32
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 31
Diabetes in chronic liver disease: from old concepts to new evidence 30
Anestesia e malattie non comuni 29
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 29
Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia 29
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 29
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 29
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 28
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 28
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 28
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 28
TNF-alpha and growth hormone resistance in patients with chronic liver disease 27
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 27
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 27
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 27
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 26
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 26
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 26
[A 73-year-old woman with vomiting and metabolic alkalosis] 26
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 26
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 25
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 25
Viral cirrhosis with chronic right heart failure and cardiac liver sclerosis: a hypothesis on the differentiation between the two diseases through pulsed Doppler sonography examination 25
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 25
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 25
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 25
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 25
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 25
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 24
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 24
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 24
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 24
Radiofrequency ablation of hepatic tissue: a new experimental animal model 24
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 24
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 24
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 23
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 23
[A 61-year-old woman with abdominal pain and urination disorders] 23
Anesthesia & uncommon diseases 23
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 23
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 23
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 23
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 22
Blood glucose monitoring in the normal population: the PREDICA study 22
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 22
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 22
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 22
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 21
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 21
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 21
Breathprinting of liver diseases 21
Raised C-reactive protein in recent onset type 1 diabetes 21
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 21
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 20
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 20
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 20
EFFICACY OF ENTECAVIR AS RESCUE THERAPY IN LAMIVUDINE-RESISTANT PATIENTS WITH HBV LIVER CIRRHOSIS AND WAITING FOR ORTHOTOPIC LIVER TRANSPLANTATION 20
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 20
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 20
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 20
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 20
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 19
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 19
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 19
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 19
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 19
Assessment of liver function by the exhaled breath-print during chronic liver disease 19
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 19
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 19
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 19
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 19
Low levels of 25-hydroxyvitamin D-3 and 1,25-dihydroxyvitamin D-3 in patients with newly diagnosed type 1 diabetes 19
[A 74-year-old woman with macrocytic anemia] 19
Raised C-reactive protein levels in patients with recent onset type 1 diabetes 19
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 19
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 19
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 19
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 19
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 19
[Hepatocarcinoma: from epidemiology to gene therapy] 18
A challenging alfa-fetoprotein in a cirrhotic patient 18
Hepatic complications of bariatric surgery : the reverse side of the coin 18
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 18
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 18
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 18
The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen 18
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 18
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 18
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 18
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 17
Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension 17
Isolated hepatocytes versus hepatocyte spheroids: in vitro culture of rat hepatocytes 17
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b 17
HGV: a "confusing" guest. 17
Totale 2.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022394 0 2 9 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/20252.786 146 74 306 50 192 279 163 39 646 801 90 0
Totale 4.122